{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:10:47Z","timestamp":1779163847748,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"DST-FIST, Government of India","award":["SR\/FST\/College-054\/2017"],"award-info":[{"award-number":["SR\/FST\/College-054\/2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01869-x","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:22:54Z","timestamp":1779160974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective effect of sigma-1-receptor agonist 1,3-di-o-tolylguanidine in rotenone-induced model of Parkinson\u2019s disease in rats"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3116-043X","authenticated-orcid":false,"given":"Talha","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-9300","authenticated-orcid":false,"given":"Lokesh Kumar","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"1869_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM et al (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Prim 7:47. https:\/\/doi.org\/10.1038\/s41572-021-00280-3","journal-title":"Nat Rev Dis Prim"},{"key":"1869_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/156720206776875849","volume":"3","author":"CTJ Ajmo","year":"2006","unstructured":"Ajmo CTJ, Vernon DOL, Collier L et al (2006) Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats. Curr Neurovasc Res 3:89\u201398. https:\/\/doi.org\/10.2174\/156720206776875849","journal-title":"Curr Neurovasc Res"},{"key":"1869_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1021\/acschemneuro.0c00722","volume":"12","author":"HH Arab","year":"2021","unstructured":"Arab HH, Safar MM, Shahin NN (2021) Targeting ROS-Dependent AKT\/GSK-3\u03b2\/NF-\u03baB and DJ-1\/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson\u2019s Disease Rat Model. ACS Chem Neurosci 12:689\u2013703. https:\/\/doi.org\/10.1021\/acschemneuro.0c00722","journal-title":"ACS Chem Neurosci"},{"key":"1869_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11064-020-03186-w","volume":"46","author":"B Avc\u0131","year":"2021","unstructured":"Avc\u0131 B, G\u00fcnayd\u0131n C, G\u00fcven\u00e7 T et al (2021) Idebenone Ameliorates Rotenone-Induced Parkinson\u2019s Disease in Rats Through Decreasing Lipid Peroxidation. Neurochem Res 46:513\u2013522. https:\/\/doi.org\/10.1007\/s11064-020-03186-w","journal-title":"Neurochem Res"},{"key":"1869_CR5","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.jchemneu.2020.101890","volume":"112","author":"R Balakrishnan","year":"2021","unstructured":"Balakrishnan R, Vijayraja D, Mohankumar T et al (2021) Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson\u2019s disease. J Chem Neuroanat 112:101890. https:\/\/doi.org\/10.1016\/j.jchemneu.2020.101890","journal-title":"J Chem Neuroanat"},{"key":"1869_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G et al (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3:1301\u20131306. https:\/\/doi.org\/10.1038\/81834","journal-title":"Nat Neurosci"},{"key":"1869_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11011-021-00705-8","volume":"36","author":"M Bigham","year":"2021","unstructured":"Bigham M, Mohammadipour A, Hosseini M et al (2021) Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson\u2019s disease: motor and non-motor outcomes. Metab Brain Dis 36:927\u2013937. https:\/\/doi.org\/10.1007\/s11011-021-00705-8","journal-title":"Metab Brain Dis"},{"key":"1869_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM et al (2009) A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol Dis 34:279\u2013290. https:\/\/doi.org\/10.1016\/j.nbd.2009.01.016","journal-title":"Neurobiol Dis"},{"key":"1869_CR9","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1016\/j.wneu.2021.11.008","volume":"158","author":"L-A Dai","year":"2022","unstructured":"Dai L-A, Chen X-Y, Li W-J et al (2022) Sigma-1 Receptor and Binding Immunoglobulin Protein Interact with Ulinastatin Contributing to a Protective Effect in Rat Cerebral Ischemia\/Reperfusion. World Neurosurg 158:e488\u2013e494. https:\/\/doi.org\/10.1016\/j.wneu.2021.11.008","journal-title":"World Neurosurg"},{"key":"1869_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0006-8993(94)01294-r","volume":"671","author":"MA DeCoster","year":"1995","unstructured":"DeCoster MA, Klette KL, Knight ES, Tortella FC (1995) Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res 671:45\u201353. https:\/\/doi.org\/10.1016\/0006-8993(94)01294-r","journal-title":"Brain Res"},{"key":"1869_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/bs.irn.2017.01.004","volume":"132","author":"R Erro","year":"2017","unstructured":"Erro R, Stamelou M (2017) The Motor Syndrome of Parkinson\u2019s Disease. Int Rev Neurobiol 132:25\u201332. https:\/\/doi.org\/10.1016\/bs.irn.2017.01.004","journal-title":"Int Rev Neurobiol"},{"key":"1869_CR12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/cns.13805","volume":"28","author":"H Fikry","year":"2022","unstructured":"Fikry H, Saleh LA, Abdel Gawad S (2022) Neuroprotective effects of curcumin on the cerebellum in a rotenone-induced Parkinson\u2019s Disease Model. CNS Neurosci Ther 28:732\u2013748. https:\/\/doi.org\/10.1111\/cns.13805","journal-title":"CNS Neurosci Ther"},{"key":"1869_CR13","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/brain\/awu107","volume":"137","author":"V Francardo","year":"2014","unstructured":"Francardo V, Bez F, Wieloch T et al (2014) Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. Brain 137:1998\u20132014. https:\/\/doi.org\/10.1093\/brain\/awu107","journal-title":"Brain"},{"key":"1869_CR14","doi-asserted-by":"publisher","first-page":"780588","DOI":"10.3389\/fphar.2021.780588","volume":"12","author":"N Gaja-Capdevila","year":"2021","unstructured":"Gaja-Capdevila N, Hern\u00e1ndez N, Navarro X, Herrando-Grabulosa M (2021) Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1(G93A) ALS Mice. Front Pharmacol 12:780588. https:\/\/doi.org\/10.3389\/fphar.2021.780588","journal-title":"Front Pharmacol"},{"key":"1869_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12017-019-08590-2","volume":"22","author":"D Garabadu","year":"2020","unstructured":"Garabadu D, Agrawal N (2020) Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents. Neuromolecular Med 22:314\u2013330. https:\/\/doi.org\/10.1007\/s12017-019-08590-2","journal-title":"Neuromolecular Med"},{"key":"1869_CR16","doi-asserted-by":"publisher","first-page":"21975","DOI":"10.1038\/s41598-021-01077-w","volume":"11","author":"M Geva","year":"2021","unstructured":"Geva M, Gershoni-Emek N, Naia L et al (2021) Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma. Sci Rep 11:21975. https:\/\/doi.org\/10.1038\/s41598-021-01077-w","journal-title":"Sci Rep"},{"key":"1869_CR17","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1523\/JNEUROSCI.06-06-01757.1986","volume":"6","author":"AL Gundlach","year":"1986","unstructured":"Gundlach AL, Largent BL, Snyder SH (1986) Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1- propyl)piperidine. J Neurosci 6:1757\u20131770. https:\/\/doi.org\/10.1523\/JNEUROSCI.06-06-01757.1986","journal-title":"J Neurosci"},{"key":"1869_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/01616412.2017.1352185","volume":"39","author":"Z Hadadianpour","year":"2017","unstructured":"Hadadianpour Z, Fatehi F, Ayoobi F et al (2017) The effect of orexin-A on motor and cognitive functions in a rat model of Parkinson\u2019s disease. Neurol Res 39:845\u2013851. https:\/\/doi.org\/10.1080\/01616412.2017.1352185","journal-title":"Neurol Res"},{"key":"1869_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1517\/14728222.2011.560837","volume":"15","author":"T Hayashi","year":"2011","unstructured":"Hayashi T, Tsai S-Y, Mori T et al (2011) Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders. Expert Opin Ther Targets 15:557\u2013577. https:\/\/doi.org\/10.1517\/14728222.2011.560837","journal-title":"Expert Opin Ther Targets"},{"key":"1869_CR20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/bph.15224","volume":"178","author":"M Herrando-Grabulosa","year":"2021","unstructured":"Herrando-Grabulosa M, Gaja-Capdevila N, Vela JM, Navarro X (2021) Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis. Br J Pharmacol 178:1336\u20131352. https:\/\/doi.org\/10.1111\/bph.15224","journal-title":"Br J Pharmacol"},{"key":"1869_CR21","doi-asserted-by":"publisher","first-page":"119009","DOI":"10.1016\/j.jep.2024.119009","volume":"338","author":"X Hou","year":"2025","unstructured":"Hou X, Liang X, Zhao X et al (2025) Uncaria rhynchophylla alkaloid extract exerts neuroprotective activity against Parkinson\u2019s disease via activating mitophagy with the involvement of UCHL1. J Ethnopharmacol 338:119009. https:\/\/doi.org\/10.1016\/j.jep.2024.119009","journal-title":"J Ethnopharmacol"},{"key":"1869_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","volume":"144","author":"L Iovino","year":"2020","unstructured":"Iovino L, Tremblay ME, Civiero L (2020) Glutamate-induced excitotoxicity in Parkinson\u2019s disease: The role of glial cells. J Pharmacol Sci 144:151\u2013164. https:\/\/doi.org\/10.1016\/j.jphs.2020.07.011","journal-title":"J Pharmacol Sci"},{"key":"1869_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11064-024-04282-x","volume":"50","author":"SA Khodir","year":"2024","unstructured":"Khodir SA, Sweed EM, Faried MA et al (2024) Neuroprotective Effect of Maresin-1 in Rotenone-Induced Parkinson\u2019s Disease in Rats: The Putative Role of the JAK\/STAT Pathway. Neurochem Res 50:30. https:\/\/doi.org\/10.1007\/s11064-024-04282-x","journal-title":"Neurochem Res"},{"key":"1869_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41419-019-1364-0","volume":"10","author":"Z Lei","year":"2019","unstructured":"Lei Z, Cao G, Wei G (2019) A30P mutant \u03b1-synuclein impairs autophagic flux by inactivating JNK signaling to enhance ZKSCAN3 activity in midbrain dopaminergic neurons. Cell Death Dis 10:133. https:\/\/doi.org\/10.1038\/s41419-019-1364-0","journal-title":"Cell Death Dis"},{"key":"1869_CR25","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.bbi.2024.10.039","volume":"123","author":"RL McFleder","year":"2025","unstructured":"McFleder RL, Musacchio T, Keller J et al (2025) Deep brain stimulation halts Parkinson\u2019s disease-related immune dysregulation in the brain and peripheral blood. Brain Behav Immun 123:851\u2013862. https:\/\/doi.org\/10.1016\/j.bbi.2024.10.039","journal-title":"Brain Behav Immun"},{"key":"1869_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40478-020-0894-0","volume":"8","author":"C McKinnon","year":"2020","unstructured":"McKinnon C, De Snoo ML, Gondard E et al (2020) Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by \u03b1-synuclein. Acta Neuropathol Commun 8:17. https:\/\/doi.org\/10.1186\/s40478-020-0894-0","journal-title":"Acta Neuropathol Commun"},{"key":"1869_CR27","doi-asserted-by":"publisher","unstructured":"Merghany RM, El-Sawi SA, Naser AFA et al (2025) Pelargonium graveolens Attenuates Rotenone-Induced Parkinson\u2019s Disease in a Rat Model: Role of MAO-B Inhibition and In Silico Study. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-04727-6","DOI":"10.1007\/s12035-025-04727-6"},{"key":"1869_CR28","doi-asserted-by":"publisher","first-page":"108977","DOI":"10.1016\/j.neuropharm.2022.108977","volume":"208","author":"D Nemutlu Samur","year":"2022","unstructured":"Nemutlu Samur D, Ak\u00e7ay G, Y\u0131ld\u0131r\u0131m S et al (2022) Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson\u2019s disease via targeting TLR-2 mediated neuroinflammation. Neuropharmacology 208:108977. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.108977","journal-title":"Neuropharmacology"},{"key":"1869_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jphs.2014.12.005","volume":"127","author":"L Nguyen","year":"2015","unstructured":"Nguyen L, Lucke-Wold BP, Mookerjee SA et al (2015) Role of sigma-1 receptors in neurodegenerative diseases. J Pharmacol Sci 127:17\u201329. https:\/\/doi.org\/10.1016\/j.jphs.2014.12.005","journal-title":"J Pharmacol Sci"},{"key":"1869_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuroscience.2022.11.036","volume":"510","author":"A Piechal","year":"2023","unstructured":"Piechal A, Jakimiuk A, Pyrzanowska J et al (2023) Long-term Administration of 3-Di-O-Tolylguanidine Modulates Spatial Learning and Memory in Rats and Causes Transition in the Concentration of Neurotransmitters in the Hippocampus, Prefrontal Cortex and Striatum. Neuroscience 510:129\u2013146. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.11.036","journal-title":"Neuroscience"},{"key":"1869_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.5607\/en.2013.22.3.214","volume":"22","author":"N Sharma","year":"2013","unstructured":"Sharma N, Nehru B (2013) Beneficial Effect of Vitamin E in Rotenone Induced Model of PD: Behavioural, Neurochemical and Biochemical Study. Exp Neurobiol 22:214\u2013223. https:\/\/doi.org\/10.5607\/en.2013.22.3.214","journal-title":"Exp Neurobiol"},{"key":"1869_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuint.2018.02.010","volume":"116","author":"S Sharma","year":"2018","unstructured":"Sharma S, Kumar P, Deshmukh R (2018) Neuroprotective potential of spermidine against rotenone induced Parkinson\u2019s disease in rats. Neurochem Int 116:104\u2013111. https:\/\/doi.org\/10.1016\/j.neuint.2018.02.010","journal-title":"Neurochem Int"},{"key":"1869_CR33","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1007\/s11064-023-03960-6","volume":"48","author":"T Siddiqui","year":"2023","unstructured":"Siddiqui T, Bhatt LK (2023) Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson\u2019s Disease. Neurochem Res 48:2925\u20132935. https:\/\/doi.org\/10.1007\/s11064-023-03960-6","journal-title":"Neurochem Res"},{"key":"1869_CR34","first-page":"1149","volume":"55","author":"G Skuza","year":"2003","unstructured":"Skuza G, Rog\u00f3z Z (2003) Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats. Pol J Pharmacol 55:1149\u20131152","journal-title":"Pol J Pharmacol"},{"key":"1869_CR35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.neuroscience.2012.11.006","volume":"231","author":"P Thakur","year":"2013","unstructured":"Thakur P, Nehru B (2013) Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson\u2019s disease. Neuroscience 231:420\u2013431. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.11.006","journal-title":"Neuroscience"},{"key":"1869_CR36","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.freeradbiomed.2019.02.001","volume":"134","author":"J Wang","year":"2019","unstructured":"Wang J, Zhao J, Cui X et al (2019) The molecular chaperone sigma 1 receptor mediates rescue of retinal cone photoreceptor cells via modulation of NRF2. Free Radic Biol Med 134:604\u2013616. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.02.001","journal-title":"Free Radic Biol Med"},{"key":"1869_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12906-019-2738-7","volume":"20","author":"T Wang","year":"2020","unstructured":"Wang T, Li C, Han B et al (2020) Neuroprotective effects of Danshensu on rotenone-induced Parkinson\u2019s disease models in vitro and in vivo. BMC Complement Med Ther 20:20. https:\/\/doi.org\/10.1186\/s12906-019-2738-7","journal-title":"BMC Complement Med Ther"},{"key":"1869_CR38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0022-3565(24)36806-5","volume":"282","author":"ER Whittemore","year":"1997","unstructured":"Whittemore ER, Ilyin VI, Woodward RM (1997) Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. J Pharmacol Exp Ther 282:326\u2013338","journal-title":"J Pharmacol Exp Ther"},{"key":"1869_CR39","doi-asserted-by":"publisher","unstructured":"Yang K, Wang C, Sun T (2019) The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson\u2019s Disease (PD) and Major Depressive Disorder (MDD). Front Pharmacol 10\u20132019. https:\/\/doi.org\/10.3389\/fphar.2019.00528","DOI":"10.3389\/fphar.2019.00528"},{"key":"1869_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2011.10.053","volume":"1431","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Shi Y, Qiao L et al (2012) Sigma-1 receptor agonists provide neuroprotection against gp120 via a change in bcl-2 expression in mouse neuronal cultures. Brain Res 1431:13\u201322. https:\/\/doi.org\/10.1016\/j.brainres.2011.10.053","journal-title":"Brain Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01869-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01869-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01869-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:22:58Z","timestamp":1779160978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01869-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1869"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01869-x","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}